In the management of pregnant patients, which medication is typically contraindicated for pain control?

In the management of pain in pregnant patients, nonsteroidal anti-inflammatory drugs (NSAIDs) are typically contraindicated, especially in the third trimester. This is largely due to their effects on the fetus and potential complications during pregnancy.

NSAIDs can cause early closure of the ductus arteriosus, a vital blood vessel in the fetal circulatory system, leading to pulmonary complications in the newborn. They also pose risks for potential kidney damage in the fetus and can inhibit important placental functions. For these reasons, healthcare providers often recommend alternative analgesics, such as acetaminophen, during pregnancy when pain relief is necessary.

Magnesium sulfate is primarily used for seizure prophylaxis in patients with severe preeclampsia or eclampsia, and while it is not a pain relief medication, it has its own specific therapeutic indications. Acetaminophen is considered safe for use during pregnancy for pain relief. Codeine, though an opioid, can be prescribed in certain cases; however, it carries risks like dependence and withdrawal in the newborn if used in the later stages of pregnancy.